Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Is Pfizer Inc. PFE the Best Pharma Dividend Stock to Buy In 2024

January 01, 2025
Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies, is gaining attention as investors seek out stable dividend stocks. With the COVID-19 pandemic driving demand for healthcare products, Pfizer is well-positioned to deliver strong profits and consistent dividend payments. In addition to its established products, the company's robust pipeline of innovative drugs offers potential for future growth. This makes Pfizer an attractive option for dividend investors looking for both stability and potential upside. Stocks Prognosis, a leading team of financial experts, recommends considering Pfizer as a buy for its strong dividend performance and promising growth prospects.

Find out how the PFIZER INC. rate is expected to change

Get Forecast for PFE

Investor opinions & comments:

I'm optimistic about Pfizer's future growth potential and ability to deliver strong returns
— from NicholasEdwards at 01-04-2025 16:17
I'm not so sure about investing in pharmaceutical companies, as there can be unpredictable regulatory and pricing issues
— from EliWells at 01-04-2025 11:17
Pfizer has a long history of delivering strong profits and consistent dividends, so it's definitely worth considering
— from EmilyMiller at 01-04-2025 11:16
I've had success investing in dividend stocks in the past, so Pfizer seems like a good option
— from StockSally at 01-04-2025 06:32
The COVID-19 pandemic has increased demand for healthcare products, which benefits Pfizer's business
— from BudgetBrittany at 01-03-2025 22:33
I'm interested in learning more about Pfizer's pipeline of innovative drugs
— from ThomasHawkins at 01-03-2025 16:58
Pfizer's position as one of the largest pharmaceutical companies gives it a competitive advantage
— from LaylaFloyd at 01-03-2025 16:41
Pfizer's strong dividend performance makes it an attractive option for income investors
— from FinanceLisa at 01-03-2025 12:16
I think Pfizer could be a smart investment in the current market climate
— from DanielTaylor at 01-03-2025 04:55
I've heard good things about Pfizer's management team and their ability to navigate the pharmaceutical industry
— from InvestorIrene at 01-03-2025 02:47
I've been looking for a pharma stock to add to my portfolio and Pfizer seems like a solid choice
— from KevinWalker at 01-03-2025 02:04
Considering Pfizer as a dividend stock seems like a wise decision given its stability and potential for growth
— from CapitalChris at 01-03-2025 00:09
I'd like to see more information about Pfizer's financials and competitive landscape before considering it as a dividend stock
— from PennyParker at 01-02-2025 06:20
Pfizer's robust pipeline of innovative drugs shows promise for future growth
— from MoneyMandy at 01-02-2025 04:04
I've seen positive analyst recommendations for Pfizer as a dividend stock
— from InvestorIan at 01-02-2025 02:18
This sounds like a great opportunity to invest in a stable dividend stock
— from LucyHenderson at 01-01-2025 23:12
I'm hesitant to invest in Pfizer due to the potential for patent expirations and generic competition
— from SavingsSarah at 01-01-2025 21:57
I like Pfizer's long-term prospects and believe it could be a solid investment for 2024
— from MarketMikayla at 01-01-2025 18:31
If you want to leave a comment, then you need Login or Register





Other news for PFE

PFEJune 12, 2025PFIZER INC. Hits Price Target Forecast with 7.16% Profit  ~2 min.

On May 28, 2025, QuantWave, an automated forecasting platform, released a long signal for PFIZER INC. stock when it was trading at $23.18....

PFEJune 11, 2025PFIZER INC. Hits Price Target Forecast with 6.25% Profit, Validating QuantWave's Analytics  ~1 min.

PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....

PFEJune 10, 2025PFIZER INC. Hits Price Target Forecast with 5.47% Profit - QuantWave Prediction Success  ~1 min.

On May 22, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) at a price of 23.04 $....

PFEJune 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments  ~1 min.

Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....

PFEApril 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis  ~1 min.

PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....



Related news

ABTJanuary 2, 2025Abbott Laboratories' Fundamental Strengths Signal Future Market Correction: Stocks Prognosis  ~1 min.

Abbott Laboratories, a global healthcare company, has lately witnessed a decline in its stock performance....

REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....

PFENovember 18, 2024Pfizer Inc. Sets Strategic Vision for Future Growth at Jefferies London Healthcare Conference  ~2 min.

Pfizer Inc., a leading pharmaceutical company, is poised for a bright future as its executives share their strategic vision at the prestigious Jefferies London Healthcare Conference....

AZNDecember 9, 2024Is AstraZeneca PLC AZN the Most Profitable Pharmaceutical Stock Right Now?  ~2 min.

AstraZeneca PLC (AZN) is emerging as one of the most profitable pharmaceutical stocks in the market....

LLYDecember 1, 2024Eli Lilly and Company Invests $4.5 Billion in New Medicine Foundry for Advanced Drug Manufacturing  ~2 min.

Eli Lilly and Company, a leading pharmaceutical company, has recently announced a massive investment of $4.5 billion in the establishment of a state-of-the-art medicine foundry....